COVID-19: Tocilizumab and Baricitinib Use in Hospitalized Patients, IL-6 Inhibitors and Mortality, Infection Relapse Following Paxlovid and Prehospital Administration of Remdesivir
Comments 0
Login to view comments.
Click here to Login
